Quarterly report pursuant to Section 13 or 15(d)

Merger with Private Molecular - Pro Forma Results in Connection with Merger (Detail)

v3.8.0.1
Merger with Private Molecular - Pro Forma Results in Connection with Merger (Detail) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Business Combinations [Abstract]    
Revenue $ 5,575 $ 1,526
Net loss $ (14,201) $ (28,226)